Cargando…
Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.
IL-2, in addition to its immunomodulating and antitumour properties, induces important systemic actions, including cardiovascular, neuroendocrine and metabolic effects. The present study was carried out to evaluate IL-2 effects on cholesterol metabolism. The study included 14 advanced cancer patient...
Autores principales: | Lissoni, P., Brivio, F., Pittalis, S., Perego, M. S., Ardizzoia, A., Mauri, O., Barni, S., Crispino, S., Tancini, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977488/ https://www.ncbi.nlm.nih.gov/pubmed/1931624 |
Ejemplares similares
-
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
por: Lissoni, P., et al.
Publicado: (1993) -
A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
por: Lissoni, P., et al.
Publicado: (1994) -
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients.
por: Lissoni, P., et al.
Publicado: (1996) -
Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.
por: Lissoni, P., et al.
Publicado: (1990) -
Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.
por: Lissoni, P., et al.
Publicado: (1989)